DNLI - Denali Therapeutics GAAP EPS of -$0.72 beats by $0.09 revenue of $1.27M misses by $9.89M
2023-11-07 17:20:20 ET
More on Denali Therapeutics
- Denali's New Summit: Changing Hunter Syndrome Landscape
- Seeking Alpha’s Quant Rating on Denali Therapeutics
- Historical earnings data for Denali Therapeutics
- Financial information for Denali Therapeutics
For further details see:
Denali Therapeutics GAAP EPS of -$0.72 beats by $0.09, revenue of $1.27M misses by $9.89M